Kim et al., FASEB J 2003
(Neovascularization, Pathologic) :
BTC induced ERK1/2 and Akt phosphorylation in a dose- and time dependent manner
Saito et al., Endocrinology 2004
:
Expression of a dominant interfering MEK kinase 1 (MEKK1) and Y1068F EGFR more efficiently blocked the enhanced Erk activation by BTC , compared with EGF ... The increased Erk activation by BTC associated with antiapoptotic function
O-charoenrat et al., Int J Cancer 2004
(Carcinoma, Squamous Cell...) :
BTC induced ERK1/2 , JNK/SAPK and Akt phosphorylation with differing kinetics but not p38 kinase